drugset / Trial / NCT04782661
A Study of JNJ-70075200 in Healthy Participants
RandomizedSequentialDouble-blindOther
Summary
The purpose of the study is to evaluate safety and tolerability of JNJ-70075200 compared with placebo after administration of single ascending doses of JNJ-70075200 as oral solution (Part 1); multiple ascending doses of JNJ-70075200, administered as oral solution over 14 consecutive days (Part 2); and the option of a single dose of JNJ-70075200 administered as an oral solid formulation (Part 3).
Timeline
- Start
- 2022-03-01
- Primary completion
- 2022-05-09
- Completion
- 2022-09-23
Outcome
Outcome not reported
Stopped (Enrollment): “Program terminated prior to enrolling subjects”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-70075200 | Unknown | — | Oral |
Indications
No indication recorded.